Wells Fargo analyst Mohit Bansal upgraded Biogen (BIIB) to Overweight from Equal Weight with a $250 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIIB:
- Spotify, Sandisk, Natera, Biogen, Tesla Trending With Analysts
- Wells Fargo downgrades Apellis to Equal Weight following Biogen’s acquisition
- Tesla upgraded, AppLovin initiated: Wall Street’s top analyst calls
- Biogen upgraded to Overweight from Neutral at Piper Sandler
- Biogen price target lowered to $189 from $193 at Truist